EUVIMEDScopri EUVIMED
EditorialKommentar

Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?

Luciano Revelli, Melisa Dirchwolf iD

Alimentary Pharmacology & Therapeutics · 2024

DOI: 10.1111/apt.17940 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, 2024. Written by Luciano Revelli and 1 co-authors. Institution: Liver Unit, Hospital Privado de Rosario, Santa Fe, Argentina. Major MEDLINE topics: Terlipressin, Liver Cirrhosis, Vasoconstrictor Agents. Cited 1 times so far (Crossref); 8 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

LINKED CONTENT This article is linked to Mücke et al paper. To view this article, visit https://doi.org/10.1111/apt.17899

Subjects

MeSH terms (MEDLINE)

TerlipressinLiver CirrhosisVasoconstrictor AgentsHumansLypressin

Substances

TerlipressinVasoconstrictor AgentsLypressin

Authors and institutions

  • Liver Unit, Hospital Privado de Rosario, Santa Fe, Argentina.

ORCID profiles: Melisa Dirchwolf

Cite

APA

Revelli, L., & Dirchwolf, M. (2024). Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17940

Vancouver

Revelli L, Dirchwolf M. Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17940

BibTeX
@article{Revelli2024,
  author = {Revelli, Luciano and Dirchwolf, Melisa},
  title = {Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1111/apt.17940}
}
Start for free →